Security key
82686Q101
Silence Therapeutics plc - Ordinary share, nominal value 0.05 GBP per share (SLN)
CUSIP: 82686Q101
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Ordinary share, nominal value 0.05 GBP per share
- Total 13F shares
- 1,955,799
- Total 13F value
- $39,359,000
- Share change
- -305,634
- SEC-reported price per share
- $20.61
- Number of holders
- 7
- Value change
- -$5,425,406
- Number of buys
- 3
- Number of sells
- 2
- Shares outstanding
- 141,918,771
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
7
Top holders
7
SLN full security history
Ownership snapshot
Full 13F holder table
Silence Therapeutics plc SEC filings
Silence Therapeutics plc company facts
Broader feeds
Ownership snapshot
Top reported holders of SLN - Silence Therapeutics plc - Ordinary share, nominal value 0.05 GBP per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lombard Odier Asset Manag...
Disclosed value leader
Lombard Odier Asset Manag...
Comparable rows
6/6
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 0.64%
Quick read
Lombard Odier Asset Management (USA) Corp leads the comparable SEC ownership view at 0.64%.
6 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lombard Odier Asset Management (USA) Corp's linked filing trail.
Comparable ownership
Top 5
Lombard Odier Asset Management (U...
0.64%
BVF INC/IL
0.47%
ADAGE CAPITAL PARTNERS GP, L.L.C.
0.31%
Consonance Capital Management LP
0.16%
MORGAN STANLEY
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (USA) Corp |
13F
Company
|
0.64%
|
$21,608,000
913,134 shares
|
— | 30 Jun 2021 |
| BVF INC/IL |
13F
Company
|
0.47%
|
$17,007,000
666,666 shares
|
— | 30 Jun 2021 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
0.31%
|
$11,629,000
444,444 shares
|
— | 30 Jun 2021 |
| Consonance Capital Management LP |
13F
Company
|
0.16%
|
$5,779,000
222,222 shares
|
— | 30 Jun 2021 |
| MORGAN STANLEY |
13F
Company
|
0.01%
|
$250,000
9,565 shares
|
— | 30 Jun 2021 |
| SG Americas Securities, LLC |
13F
Company
|
0%
|
$138,000
5,402 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
1,955,799
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
6
Q3 2021 holders
7
Holder diff
1
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|